Germany’s Merck to Boost Lab-Tools Business With $11 Billion Bio-Techne Deal
The proposed acquisition will be the company’s biggest deal in more than a decade and represents an early move by new CEO Kai Beckmann to bolster the business.
Connecting Global Economies
The proposed acquisition will be the company’s biggest deal in more than a decade and represents an early move by new CEO Kai Beckmann to bolster the business.